Study title: Study to determine the safety and efficacy of long-term administration of Alupent syrup for the treatment of bronchial asthma in children.
Type of medicine: Medicines containing chemical active substances | |||||
Therapeutic area: Respiratory Tract Diseases | |||||
Brands: Please see report, Please see report | |||||
MAH holders: Please see report, Please see report | |||||
Assessment: | |||||
Active substance: ORCIPRENALINE | |||||
ATC code: R03CB03 | |||||
Document link: | |||||
Document date: | |||||
Study number: U72-0640 (A69-522) | |||||
EudraCT number: | |||||
Scope of study: Clinical | |||||
Population of study subjects: | Preterm newborn Infants | Newborn infants (1 to 27 days) | Infants and toddlers (28 days to 24 months) | Children (2 to 11 years) | Adolescents (12 to 18 years) |
- | - | - | - | - |